Tumor markers such as alpha fetoprotein (AFP), carcinoembryonic antigen (CEA), cancer antigen 125 (CA125) and cancer antigen 19–9 (CA19-9) have been widely used for the diagnosis of different types of cancers such as liver cancer, colorectal cancer and pancreatic cancer. This evidence concerns the gene MUC16 and pancreatic neoplasm.